Notorious “Pharma Bro” Martin Shkreli is going to have to wade through a bit more red tape as prosecutors are adding charges to his rap sheet concerning his lack of transparency.
U.S. prosecutors announced on Friday that they were adding another charge to Shkreli’s case, concerned that he had tried to hide his level of control from investors over shares of Retrophin Inc. This additional charge brings Shkreli’s case up to 8 charges he will have to face.
Shkreli, who has already pleaded not guilty to the previous 7 charges will no doubt make the same claim of the 8th. Shkreli’s lawyer, Benjamin Brafman, issued this statement about the additional charge:
“The new indictment adds nothing of value to the government’s case that still relies on a flawed theory as to Mr. Shkreli.”
Shkreli became well-known and infamous for his gross inflation of an HIV medication. Though there were no laws in place to prosecute the man for his greed, his bad habits caught up to him elsewhere, resulting in his arrest in December of 2015.
Shkreli is expected to go to trial for his eight counts in 2016 or 2017.
